2022 Q3 Form 10-Q Financial Statement
#000121390022047356 Filed on August 12, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
Revenue | $5.413M | $6.086M | $6.951M |
YoY Change | 5.4% | 24.03% | 73.16% |
Cost Of Revenue | $2.052M | $1.836M | $2.204M |
YoY Change | 4.08% | -4.1% | 51.54% |
Gross Profit | $3.361M | $4.250M | $4.747M |
YoY Change | 6.22% | 42.02% | 85.45% |
Gross Profit Margin | 62.09% | 69.83% | 68.3% |
Selling, General & Admin | $3.706M | $5.604M | $5.807M |
YoY Change | -9.16% | -9.64% | 61.79% |
% of Gross Profit | 110.27% | 131.87% | 122.32% |
Research & Development | $1.374M | $1.761M | $2.105M |
YoY Change | -12.28% | 15.33% | 47.84% |
% of Gross Profit | 40.89% | 41.45% | 44.35% |
Depreciation & Amortization | $2.119M | $1.983M | $1.993M |
YoY Change | 71.08% | 50.56% | 89.33% |
% of Gross Profit | 63.04% | 46.66% | 41.99% |
Operating Expenses | $4.199M | $33.47M | $25.38M |
YoY Change | -39.01% | 270.11% | 318.47% |
Operating Profit | -$838.0K | -$29.22M | -$20.64M |
YoY Change | -77.48% | 382.91% | 488.61% |
Interest Expense | -$396.0K | -$213.0K | -$740.00 |
YoY Change | 66.2% | 30.56% | -100.1% |
% of Operating Profit | |||
Other Income/Expense, Net | -$1.507M | -$473.1K | -$1.416M |
YoY Change | -169.52% | 924.95% | -51.87% |
Pretax Income | -$2.345M | -$29.69M | -$22.05M |
YoY Change | 50.94% | 387.01% | 242.02% |
Income Tax | -$40.67K | -$128.0K | -$99.44K |
% Of Pretax Income | |||
Net Earnings | -$2.304M | -$29.57M | -$21.95M |
YoY Change | 48.32% | 384.27% | 239.95% |
Net Earnings / Revenue | -42.57% | -485.81% | -315.83% |
Basic Earnings Per Share | -$0.59 | ||
Diluted Earnings Per Share | -$0.59 | -$0.83 | -$694.6K |
COMMON SHARES | |||
Basic Shares Outstanding | 80.29M shares | 34.96M shares | 32.05M shares |
Diluted Shares Outstanding | 3.884M shares | 35.48M shares | 1.580M shares |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.491M | $5.125M | $9.688M |
YoY Change | -74.08% | -56.49% | -37.22% |
Cash & Equivalents | $2.491M | $5.125M | $9.688M |
Short-Term Investments | |||
Other Short-Term Assets | $8.497M | $1.431M | $2.453M |
YoY Change | 248.61% | -46.47% | 20.23% |
Inventory | |||
Prepaid Expenses | $2.330M | $2.155M | $2.492M |
Receivables | $1.371M | $1.882M | $2.579M |
Other Receivables | $841.5K | $733.1K | $547.7K |
Total Short-Term Assets | $13.20M | $9.170M | $15.27M |
YoY Change | -5.44% | -44.35% | -23.32% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $124.8K | $143.0K | $159.2K |
YoY Change | 138.45% | 168.07% | -86.03% |
Goodwill | $9.026M | $9.080M | $29.96M |
YoY Change | -80.71% | -80.59% | -28.44% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | $226.1K | $226.1K | $226.1K |
YoY Change | 0.0% | 0.0% | -1.7% |
Other Assets | $9.700K | $9.700K | |
YoY Change | |||
Total Long-Term Assets | $32.39M | $34.00M | $59.08M |
YoY Change | -46.5% | -43.39% | 8.56% |
TOTAL ASSETS | |||
Total Short-Term Assets | $13.20M | $9.170M | $15.27M |
Total Long-Term Assets | $32.39M | $34.00M | $59.08M |
Total Assets | $45.59M | $43.17M | $74.35M |
YoY Change | -38.81% | -43.6% | 0.02% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.271M | $3.793M | $3.066M |
YoY Change | -29.75% | 236.72% | 518.34% |
Accrued Expenses | $2.276M | $2.337M | $3.208M |
YoY Change | -32.61% | -34.27% | 25.31% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | $9.900M | $6.600M | $13.20M |
YoY Change | -7.77% | 50.34% | |
Total Short-Term Liabilities | $19.99M | $22.37M | $30.38M |
YoY Change | 219.65% | 67.26% | 126.11% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $4.575M | $6.788M | $2.137M |
YoY Change | 19.33% | 465.36% | 89.12% |
Other Long-Term Liabilities | $499.2K | $602.1K | $486.2K |
YoY Change | |||
Total Long-Term Liabilities | $4.575M | $6.788M | $2.137M |
YoY Change | 19.33% | 465.36% | 89.12% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $19.99M | $22.37M | $30.38M |
Total Long-Term Liabilities | $4.575M | $6.788M | $2.137M |
Total Liabilities | $25.50M | $30.22M | $33.57M |
YoY Change | 152.74% | 107.4% | 130.49% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$142.3M | -$140.0M | -$110.5M |
YoY Change | 99.63% | 100.78% | 73.58% |
Common Stock | $159.8M | $150.4M | $148.8M |
YoY Change | 20.36% | 21.46% | 34.14% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $20.09M | $12.95M | $40.78M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $45.59M | $43.17M | $74.35M |
YoY Change | -38.81% | -43.6% | 0.02% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.304M | -$29.57M | -$21.95M |
YoY Change | 48.32% | 384.27% | 239.95% |
Depreciation, Depletion And Amortization | $2.119M | $1.983M | $1.993M |
YoY Change | 71.08% | 50.56% | 89.33% |
Cash From Operating Activities | -$3.263M | -$3.602M | -$3.585M |
YoY Change | 139.55% | 53.59% | 160.98% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.587M | -$1.117M | -$647.0K |
YoY Change | 16.57% | -14.34% | -7.57% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $400.0K | |
YoY Change | |||
Cash From Investing Activities | -$1.587M | -$717.5K | -$647.0K |
YoY Change | 16.57% | -45.0% | -8.18% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 9.262M | -761.4K | -$5.615K |
YoY Change | 1554.73% | 19675.84% | -98.32% |
NET CHANGE | |||
Cash From Operating Activities | -3.263M | -3.602M | -$3.585M |
Cash From Investing Activities | -1.587M | -717.5K | -$647.0K |
Cash From Financing Activities | 9.262M | -761.4K | -$5.615K |
Net Change In Cash | 4.411M | -5.081M | -$4.247M |
YoY Change | -303.85% | 39.06% | 75.92% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$3.263M | -$3.602M | -$3.585M |
Capital Expenditures | -$1.587M | -$1.117M | -$647.0K |
Free Cash Flow | -$1.677M | -$2.485M | -$2.938M |
YoY Change | 174540.63% | 138.77% | 336.08% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001755953 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Akerna Corp. | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39096 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
83-2242651 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1550 Larimer Street | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
#246 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Denver | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CO | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
80202 | ||
dei |
City Area Code
CityAreaCode
|
(888) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
932-6537 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
KERN | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
80285241 | shares |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5124553 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13934265 | usd |
CY2022Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
8261 | usd |
CY2021Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
508261 | usd |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1882084 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1403774 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2155446 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2383764 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
9170344 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
18230064 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
143026 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
153151 | usd |
CY2022Q2 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
226101 | usd |
CY2021Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
226101 | usd |
CY2022Q2 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
6898876 | usd |
CY2021Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
7311676 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
17640833 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
21609794 | usd |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
9080177 | usd |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
46942681 | usd |
CY2022Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
9700 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
9700 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
43169057 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
94483167 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q2 | kern |
Exchangable Preferred Stock
ExchangablePreferredStock
|
2227619 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
7050679 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6063520 | usd |
CY2022Q2 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
6300000 | usd |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
6300000 | usd |
CY2022Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2403512 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
3543819 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
6600000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
13200000 | usd |
CY2022Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
11282 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
63178 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
22365473 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
29170517 | usd |
CY2022Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
602086 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
582676 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
6788000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
4105000 | usd |
CY2022Q2 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
468486 | usd |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
675291 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
30224045 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
34533484 | usd |
CY2022Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2021Q4 | kern |
Exchangable Preferred Stock
ExchangablePreferredStock
|
2366038 | usd |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
36826733 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
36826733 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31001884 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31001884 | shares |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
3680 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
3100 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
150438437 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
146027258 | usd |
CY2022Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
302352 | usd |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
61523 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-140027076 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-88508236 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12945012 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59949683 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
43169057 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
94483167 | usd |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
4906887 | usd |
us-gaap |
Revenues
Revenues
|
13036722 | usd | |
us-gaap |
Revenues
Revenues
|
8920911 | usd | |
CY2022Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1835977 | usd |
CY2021Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1914380 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
4039648 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
3368547 | usd | |
CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
4249904 | usd |
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
2992507 | usd |
us-gaap |
Gross Profit
GrossProfit
|
8997074 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
5552364 | usd | |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1761428 | usd |
CY2021Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1527258 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3866789 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2951358 | usd | |
CY2022Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
3185318 | usd |
CY2021Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1826143 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
6421431 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
3562058 | usd | |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2419109 | usd |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4375981 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4989541 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6228943 | usd | |
CY2022Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1982833 | usd |
CY2021Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1314132 | usd |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
3976224 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2367015 | usd | |
CY2022Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
24122066 | usd |
CY2021Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
usd | |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
39600587 | usd | |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
usd | ||
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
33470754 | usd |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
9043514 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
58854572 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
15109374 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-29220850 | usd |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6051007 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-49857498 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9557010 | usd | |
CY2022Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-212984 | usd |
CY2021Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-163125 | usd |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-213724 | usd | |
CY2022Q2 | kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-294000 | usd |
CY2021Q2 | kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-16405 | usd |
kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-1727000 | usd | |
kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-2007677 | usd | |
CY2022Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
33845 | usd |
CY2021Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
133125 | usd |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
51896 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-42871 | usd | |
CY2022Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
usd | |
CY2021Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
243 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
usd | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
243 | usd | |
CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-473139 | usd |
CY2021Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-46162 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1888828 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2987810 | usd | |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-29693989 | usd |
CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-6097169 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-51746326 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-12562954 | usd | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35477788 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
24530169 | shares |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12544820 | usd | |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-128042 | usd |
CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4300 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-227486 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10570 | usd | |
CY2022Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
usd | |
CY2021Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-3782 | usd |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
usd | ||
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-7564 | usd | |
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-29565947 | usd |
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-6105251 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-51518840 | usd | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
33694681 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
23375981 | shares | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.83 | |
CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.25 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.53 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.54 | ||
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-29565947 | usd |
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-6105251 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-51518840 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-12562954 | usd | |
CY2022Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
10629 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2183 | usd |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-23171 | usd | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1953 | usd | |
CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
163000 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
-3000 | usd |
us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
264000 | usd | |
us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
-16000 | usd | |
CY2022Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-29392318 | usd |
CY2021Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6106068 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-51278011 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12577001 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59949683 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
3300000 | usd |
CY2022Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
5615 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
940000 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
316855 | usd |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
usd | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-33800 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
101000 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-21952893 | usd |
CY2022Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
306852 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40780296 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
625500 | usd |
CY2022Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
7552 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
761178 | usd |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
148444 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
25000 | usd |
CY2022Q2 | kern |
Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
|
4464 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
10629 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
163000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12945012 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
57222620 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
8467500 | usd |
CY2021Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
333847 | usd |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
503379 | usd |
CY2021Q1 | kern |
Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
|
377325 | usd |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
usd | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
usd | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-230 | usd |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
-13000 | usd |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-6457702 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59766045 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1729144 | usd |
CY2021Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
6002000 | usd |
CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
571242 | usd |
CY2021Q2 | kern |
Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
|
usd | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
usd | |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
usd | |
CY2021Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2183 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
|
-3000 | usd |
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-6105251 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-51518840 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-12562954 | usd | |
us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
usd | ||
us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
7564 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
112475 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
150294 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
477681 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1074621 | usd | |
us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
usd | ||
us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
1045180 | usd | |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
39600587 | usd | |
CY2021Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
usd | |
kern |
Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
|
205408 | usd | |
kern |
Amortization Of Deferred Contract Costs
AmortizationOfDeferredContractCosts
|
242110 | usd | |
us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
60500 | usd | |
us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
926968 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
3976224 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2367014 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-14689 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
17344 | usd | |
kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-1727000 | usd | |
CY2021Q2 | kern |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-2007677 | usd |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
51896 | usd | |
CY2021Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-42871 | usd |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
580387 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-286118 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-23530 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
115934 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
119355 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1463669 | usd | |
us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-206805 | usd | |
us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
usd | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1146966 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-633052 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7187445 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3715198 | usd | |
us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
2004609 | usd | |
us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
27383 | usd | |
us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
usd | ||
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-400000 | usd | |
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1364503 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2004609 | usd | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
13167 | usd | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
333847 | usd | |
kern |
Principal Payments Of Convertible Notes
PrincipalPaymentsOfConvertibleNotes
|
-1515000 | usd | |
kern |
Principal Payments Of Convertible Notes
PrincipalPaymentsOfConvertibleNotes
|
usd | ||
us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
761178 | usd | |
us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
usd | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-766989 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-333847 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9225 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-124 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-9309712 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6053778 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14442526 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
18340640 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5132814 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12286862 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
151500 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
50854 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
19466 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
64963 | usd | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
3925500 | usd | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
10196382 | usd | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
138419 | usd | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
12453853 | usd | |
us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
49528 | usd | |
us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
377325 | usd | |
kern |
Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
|
12618 | usd | |
kern |
Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
|
usd | ||
kern |
Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
|
7 | usd | |
kern |
Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
|
usd | ||
kern |
Capitalized Software Included In Accrued Expenses
CapitalizedSoftwareIncludedInAccruedExpenses
|
1045299 | usd | |
kern |
Capitalized Software Included In Accrued Expenses
CapitalizedSoftwareIncludedInAccruedExpenses
|
usd | ||
kern |
Shares Returned In Connection With365 Cannabis Acquisition
SharesReturnedInConnectionWith365CannabisAcquisition
|
940000 | usd | |
kern |
Shares Returned In Connection With365 Cannabis Acquisition
SharesReturnedInConnectionWith365CannabisAcquisition
|
usd | ||
kern |
Cannabis Working Capital Funds Released From Accrued Expenses
CannabisWorkingCapitalFundsReleasedFromAccruedExpenses
|
160000 | usd | |
kern |
Cannabis Working Capital Funds Released From Accrued Expenses
CannabisWorkingCapitalFundsReleasedFromAccruedExpenses
|
usd | ||
us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="border-left: none; border-right: none;"> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.2;"><span>Akerna Corp., herein referred to as we, us, our, the Company or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, the Company or Ample, solo sciences, inc., or Solo, Viridian Sciences Inc., or Viridian, and The NAV People, Inc. d.b.a. 365 Cannabis, or 365 Cannabis, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform®, Trellis®, Ample, Viridian and 365 Cannabis to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through Solo, we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG™. The integration of MJ Platform® and solo*CODE™ results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency.</span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span>Our Viridian and 365 Cannabis offerings are considered enterprise offerings while all other solutions are considered non-enterprise offerings that meet the needs of our small and medium-sized business, or SMB, customers.</span><br/></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.2;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations.</p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 12pt; text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt;"><b><i><span style="font-size: 10pt; color: #000000;">Going Concern and Management's Liquidity Plans</span></i></b></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; text-align: justify; text-indent: 33.33pt; margin: 0pt 0pt 0.0001pt; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;"><span>In accordance with the Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standard Update (<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">“</span>ASU<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">”</span>) No. 2014-15, <span style="font-style: italic;">Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern</span> (<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">“</span>ASU 2014-15<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">”</span>), we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash, cash equivalents and working capital on hand, including marketable equity securities, and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is defined to as the “look-forward period” in ASU 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to us, we will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions regarding implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable that such implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASU 2014-15.<br/></span></span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 12pt; text-align: justify; text-indent: 33.33pt; margin: 0pt 0pt 0.0001pt; line-height: 1.1;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important; background-color: #ffffff;"><span><span>The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception we have incurred recurring losses from operations, used cash from operating activities, and relied on capital raising transactions to continue ongoing operations. During the six months ended <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important; background-color: #ffffff;">June 30</span>, 2022 and <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important; background-color: #ffffff;">June 30</span>, 2021, we incurred losses from operations of $49.9 million and $9.6 million, respectively, and used cash in operating activities of $7.2 million and $</span>3.7<span> million, respectively. As of June 30, 2022, we had a working capital deficit of $13.2 million with $</span>5.1</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;"><span><span><span style="background-color: #ffffff;"> million in cash available to fund future operations.</span> </span></span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; background-color: #ffffff; display: inline !important; line-height: inherit;"><span><span>Furthermore, on May 24, 2022, we received a notice (the “Notice”) from The Nasdaq Stock Market LLC indicating that the bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market (the “Nasdaq Market”). The Notice has no immediate effect on the continued listing status of our Common Stock on the Nasdaq Market, and, therefore, our listing remains fully effective. We are provided a compliance period of 180 calendar days from the date of the Notice, or until November 21, 2022, to regain compliance with the minimum closing bid requirement. These factors raise substantial doubt regarding the ability of the Company to continue as a going concern.</span></span></span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt; line-height: 1.1;"><span style="font-family: 'Times New Roman'; font-size: 4pt; line-height: inherit;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <div style="font-family: 'times new roman', times; font-size: 10pt;"> </div> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.1; font-size: 10pt;"><span><span style="font-size: 13.3333px; line-height: inherit;"> </span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;">Management’s <span>plan for the Company to continue as a going concern includes <span style="font-size: 10pt; line-height: inherit; font-family: 'times new roman', times;">several initiatives and actions including those impacting our short and intermediate term financing, continuing costs, primarily labor and employee benefits, our working capital and the liquidity of our Common Stock. Certain of these initiatives and actions began during the quarter ended June 30, 2022 while others were initiated in July 2022.</span></span></span></span></p> <p style="text-indent: 44.4444px; text-align: justify; margin: 0cm 0cm 0.0001pt; line-height: 1.2; font-size: 10pt;"><br/></p> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 8pt; line-height: 1.1; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"><span> <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">The most significant components of our plan include the following: </span><span style="border-left: none; border-right: none; line-height: inherit;"><span>(i) realizing annualized cost savings associated with the corporate restructuring initiative (the “Restructuring”) that we announced in May 2022 which resulted in a reduction in workforce and related operating costs (see Note 4), (ii) entering into an amendment and waiver agreement to the securities purchase agreement associated with our 2021 Senior Convertible Notes (the “Senior Convertible Notes”) on June 30, 2022 (the “Convertible Notes Amendment”) which, among other factors, provides for a deferral of the required amortization payments due and payable from July 1, 2022 through January 1, 2023 (see Note 4), (iii) deploying for working capital needs of the net proceeds of approximately $2 million received from our offering of Common Stock and warrants (the “Unit Offering”) in a transaction that closed on July 5, 2022 (see Note 4), net of underwriting discounts and commissions and other offering expenses and after depositing $7 million of the proceeds into certain restricted cash accounts in accordance with the Convertible Notes Amendment, (iv) conservatively managing our working capital through disciplined cost-containment efforts and strategic manag<span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">ement of our accounts receivable and accounts payable cycles (v) addressing the potential liquidity of our Common Stock in connection with the minimum listing requirements for the Nasdaq Market through a proposed </span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">1</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">-to-</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">20</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> reverse stock split (the <span style="line-height: inherit;">“</span>Reverse Stock Split”) and (vi) </span></span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> continuing to seek to grow our customer base and realize synergies as we continue to integrate our recent acquisitions</span>.</span></span></span></span></p> <p style="text-indent: 33.33pt; margin: 0pt; line-height: 1.1; font-size: 11pt; font-family: Calibri, sans-serif; text-align: justify;"><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">We anticipate the initiatives and actions described above will provide us with sufficient liquidity in order to operate our business in the normal course for the second half of 2022 until such time that the an earn-out payment associated with a 2021 acquisition is due in December 2022 (see Note 4), in part, to the fact that the debt service obligations associated with the Senior Convertible Notes for the first half of 2023 have effectively been substantially pre-funded with the amounts deposited into restricted accounts as required by the Convertible Notes Amendment. In the second half of 2022, we plan to continue to rigorously explore potential financing alternatives and other strategic options in addition to enhancing the liquidity of our Common Stock. In addition to and to the extent practical in the future, based on market conditions, we will consider incremental offerings of Common Stock through our previously authorized ATM Program; however, we do not consider this a viable alternative unless and until we are able to successfully address the minimum listing requirements of the Nasdaq Market with the proposed Reverse Stock Split. Through July 31, 2022, we have utilized $2.7 million of the total $25 million authorized by the ATM Program.</span></p> <p style="text-indent: 44.4444px; text-align: justify; margin: 0cm 0cm 0.0001pt; line-height: 1.2; font-size: 10pt;"><br/></p> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.1; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"><span> If we are unable to <span>secure other potential financing alternatives or fail to execute any other strategic options to raise sufficient additional funds through the first half of 2023, including through the ATM Program, </span> we will have to develop and implement more aggressive plans to <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">address our liquidity needs and our ability to satisfy the scheduled maturity of our obligations under the Senior Convertible Notes.</span> Such plans could include extending payables, further reductions of expenditures (including the termination of additional employees) and reducing or eliminating investments in and the funding of certain of our business units and initiatives, or otherwise substantially scale back our business plan until sufficient additional capital is raised through other equity or debt offerings. <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Such offerings may include the issuance of shares of common stock, warrants to purchase common stock, preferred stock, convertible debt or other instruments that may dilute our current stockholders.</span> Accordingly, we may be subject to additional risks, including retention of key employees and limitations on the extension of credit by our vendors and other service providers. </span></span><span>If we are required to raise additional capital as discussed above and if we cannot timely raise additional funds, we may be unable to meet the financial covenants of the Senior Convertible Notes, which could result in an event of default under those instruments which could adversely impact the Company. See the risks detailed in our Form 10-K under “Item 1A. Risk Factors – Risks Relating to our Convertible Debt”.</span></span><br/></p> <p style="font-family: 'times new roman', times; font-size: 4pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 4pt;"> </span></p> <p class="ng-scope" style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 33.33pt; line-height: 1.1;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Our ability to continue as a going concern is dependent upon our ability to successfully execute the plans described above and attain profitable operations. <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">Despite the comprehensive scope of our plans, the inherent risks associated with their successful execution are not sufficient to fully overcome </span></span><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">substantial doubt about our ability to continue as a going concern for </span>one<span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> year from the date of issuance of the consolidated financial statements. Accordingly, if we are unable to raise sufficient capital we may have to reduce operations which could significantly and adversely affect our results of operations. If we fail to meet the financial covenants of the Senior Convertible Notes and cannot obtain a waiver from such provisions or otherwise come to an agreement with the holders of our debt, such holders may declare a default on the debt which could subject our assets to seizure and sale, negatively impacting our business.</span></p> <p class="ng-scope" style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 32pt; line-height: 1.2;"><br/></p> <p class="ng-scope" style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 33.33pt; line-height: 1.3;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary if the Company is unable to continue as a going concern.</span></p> </div> | ||
kern |
Loss From Operations
LossFromOperations
|
49900000 | usd | |
kern |
Loss From Operations
LossFromOperations
|
9600000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
7200000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
3700000 | usd | |
CY2022Q2 | kern |
Working Capital
WorkingCapital
|
13200000 | usd |
CY2022Q2 | us-gaap |
Cash
Cash
|
5100000 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
kern |
Bid Price Per Share
BidPricePerShare
|
1 | ||
CY2021Q1 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
7705000 | usd |
us-gaap |
Substantial Doubt About Going Concern Conditions Or Events
SubstantialDoubtAboutGoingConcernConditionsOrEvents
|
<span>(i) realizing annualized cost savings associated with the corporate restructuring initiative (the “Restructuring”) that we announced in May 2022 which resulted in a reduction in workforce and related operating costs (see Note 4), (ii) entering into an amendment and waiver agreement to the securities purchase agreement associated with our 2021 Senior Convertible Notes (the “Senior Convertible Notes”) on June 30, 2022 (the “Convertible Notes Amendment”) which, among other factors, provides for a deferral of the required amortization payments due and payable from July 1, 2022 through January 1, 2023 (see Note 4), (iii) deploying for working capital needs of the net proceeds of approximately $2 million received from our offering of Common Stock and warrants (the “Unit Offering”) in a transaction that closed on July 5, 2022 (see Note 4), net of underwriting discounts and commissions and other offering expenses and after depositing $7 million of the proceeds into certain restricted cash accounts in accordance with the Convertible Notes Amendment, (iv) conservatively managing our working capital through disciplined cost-containment efforts and strategic manag<span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">ement of our accounts receivable and accounts payable cycles (v) addressing the potential liquidity of our Common Stock in connection with the minimum listing requirements for the Nasdaq Market through a proposed </span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">1</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">-to-</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">20</span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> reverse stock split (the <span style="line-height: inherit;">“</span>Reverse Stock Split”) and (vi) </span></span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> continuing to seek to grow our customer base and realize synergies as we continue to integrate our recent acquisitions</span>. | ||
kern |
Description Of Liquidity And Capital Resources
DescriptionOfLiquidityAndCapitalResources
|
We anticipate the initiatives and actions described above will provide us with sufficient liquidity in order to operate our business in the normal course for the second half of 2022 until such time that the an earn-out payment associated with a 2021 acquisition is due in December 2022 (see Note 4), in part, to the fact that the debt service obligations associated with the Senior Convertible Notes for the first half of 2023 have effectively been substantially pre-funded with the amounts deposited into restricted accounts as required by the Convertible Notes Amendment. In the second half of 2022, we plan to continue to rigorously explore potential financing alternatives and other strategic options in addition to enhancing the liquidity of our Common Stock. In addition to and to the extent practical in the future, based on market conditions, we will consider incremental offerings of Common Stock through our previously authorized ATM Program; however, we do not consider this a viable alternative unless and until we are able to successfully address the minimum listing requirements of the Nasdaq Market with the proposed Reverse Stock Split. Through July 31, 2022, we have utilized $2.7 million of the total $25 million authorized by the ATM Program. | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'times new roman', times;"><b><i><span style="font-size: 10.0pt;">Use of Estimates</span></i></b></span></p> <p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; ;margin: 0px !important;"><br/></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expenses, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. </span></span></span><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"><br/></span></span></span></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"><br/></span></span></span></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit; font-style: italic; font-weight: bold;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Subsequent Events</span></span></span></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit; font-style: italic; font-weight: bold;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"><br/></span></span></span></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.33pt;">Management has evaluated all of our activities through the issuance date of our condensed consolidated financial statements and has concluded that, with the exception of the issuance of common stock and warrants in an offering that closed on July 5, 2022, as disclosed in Note 4, no subsequent events have occurred that would require recognition in our condensed consolidated financial statements or disclosure in the notes thereto.</p> | ||
CY2022Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
700000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
300000 | usd |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;">Concentrations of Credit Risk</span></i></b></span></p> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3; ;margin: 0px !important;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">We grant credit in the normal course of business to customers in the United States and Canada. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. </span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; ;margin: 0px !important;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span><span style="font-size: 10pt; color: #000000; line-height: inherit;"><span>During the six<span style="border-left: none; border-right: none;"> months ended June 30, 2022</span> and 2021, one government client accounted for 11<span>% and 11%</span> of total revenues, respectively. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">As of June 30, 2022, </span>one government client accounted for 30% of net accounts receivable and as of December 31, 2021 two government clients accounted for 37% of net accounts receivable. </span></span></span></p> | ||
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | pure | |
CY2022Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
34163 | usd |
CY2021Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
37585 | usd |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13037 | usd | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
8921 | usd | |
kern |
Adjustedforadoption
Adjustedforadoption
|
13037 | usd | |
kern |
Adjustedforadoption
Adjustedforadoption
|
8921 | usd | |
CY2022Q2 | kern |
Unsatisfied Performance Obligations
UnsatisfiedPerformanceObligations
|
22300000 | usd |
kern |
Revenueexpectedtoberecognized
Revenueexpectedtoberecognized
|
11900000 | usd | |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
4126000 | usd |
us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
8881000 | usd | |
us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
10002000 | usd | |
CY2022Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
3005000 | usd |
CY2022Q2 | us-gaap |
Deferred Income
DeferredIncome
|
13000000 | usd |
CY2021Q4 | us-gaap |
Deferred Income
DeferredIncome
|
3100000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
261 | usd |
us-gaap |
Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
|
279 | usd | |
kern |
Amortized Costs
AmortizedCosts
|
246 | usd | |
CY2022Q2 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
294 | usd |
CY2022Q2 | kern |
Convertible Notes Amendment Description
ConvertibleNotesAmendmentDescription
|
we and the holders Senior Convertible Notes entered into the Convertible Notes Amendment to add covenants such that (a) we will be subject to a daily cash test beginning on July 1, 2022 of having an available cash balance of at least $7 million, which amount shall be reduced by $1 million on each of the dates at which the aggregate principal due upon the Senior Convertible Notes is equal to or less than $14 million and $11 million, subject in all cases to a minimum of $5 million, and (b) we will establish and maintain bank accounts for each holder and deposit in such accounts an aggregate amount of $7 million with such amount to be released from the accounts only upon the written consent of such holder, provided that $1 million will automatically release from the accounts upon the occurrence of each of the dates at which the aggregate principal due upon the Senior Convertible Notes is equal to or less than $14 million and $11 million, subject to certain conditions. Further the holders of the Senior Convertible Notes waived provisions such that (i) no amortization payments are due and payable for any payments previously required to be made from July 1, 2022 through January 1, 2023, (ii) the holders of the Senior Convertible Notes will not accelerate any previously deferred installment amounts until January 1, 2023 and (iii) the terms of the Senior Convertible Notes which would provide for reset of the conversion price of the Senior Convertible Notes as a result of the issuance of securities under the Unit Offering and instead agree to a reset of the conversion price equal to a per share price of 135% of the Unit Offering price, or $0.3105 per unit. | |
kern |
Descriptionofunitoffering
Descriptionofunitoffering
|
(i) 29,382,861 units of the Company consisting of 29,382,861 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 29,382,861 shares of Common Stock and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-Funded Warrants”), with each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Warrants to purchase up to 14,095,400 shares of Common Stock. The units were sold at a public offering price of $0.23 per unit and the pre-funded units were sold at a public offering price of $0.2299 per pre-funded unit. | ||
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.23 | |
us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
1 | shares | |
CY2022Q2 | us-gaap |
Share Price
SharePrice
|
0.0001 | |
kern |
Underwritingagreementdescription
Underwritingagreementdescription
|
the Underwriting Agreement, we granted the Underwriter a 45-day option from June 30, 2022 to purchase from the Company (i) additional shares of Common Stock and/or (ii) Common Warrants and/or (iii) Pre-Funded Warrants, in any combination thereof, up to, and not to exceed, 13,043,478 shares of Common Stock or shares of Common Stock underlying Pre-Funded Warrants or Common Warrants, in the aggregate, solely to cover over-allotments, if any. | ||
kern |
Commonstockofferingpercentage
Commonstockofferingpercentage
|
0.05 | pure | |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.23 | |
CY2022Q3 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
9.3 | usd |
CY2022Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
7 | usd |
CY2022Q2 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
0.5 | usd |
CY2022Q2 | us-gaap |
Marketing Expense
MarketingExpense
|
300000 | usd |
CY2022Q2 | us-gaap |
Development Costs
DevelopmentCosts
|
200000 | usd |
CY2022Q2 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
100000 | usd |
kern |
Reduction Of Purchase Price
ReductionOfPurchasePrice
|
25 | usd | |
CY2022Q2 | kern |
Exchangeable Shares
ExchangeableShares
|
1 | shares |
kern |
Reduction Of Working Capital
ReductionOfWorkingCapital
|
1.5 | usd | |
CY2022Q2 | kern |
Commonstockofferingpercentage
Commonstockofferingpercentage
|
0.25 | pure |
CY2022Q2 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
2080000 | usd |
CY2022Q2 | kern |
Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
|
470505 | usd |
CY2021Q4 | kern |
Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
|
687740 | usd |
CY2022Q2 | kern |
Prepaid Professional Fees
PrepaidProfessionalFees
|
505282 | usd |
us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
14698 | usd | |
us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
13317 | usd | |
CY2021Q2 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
7291 | usd |
CY2021Q2 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
6743 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
|
1 | |
CY2021Q4 | kern |
Prepaid Professional Fees
PrepaidProfessionalFees
|
546126 | usd |
CY2022Q2 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
74196 | usd |
CY2021Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
264097 | usd |
CY2022Q2 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
293618 | usd |
CY2021Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
260899 | usd |
CY2022Q2 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
733045 | usd |
CY2021Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
506984 | usd |
CY2022Q2 | us-gaap |
Other Assets
OtherAssets
|
78800 | usd |
CY2021Q4 | us-gaap |
Other Assets
OtherAssets
|
117918 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2155446 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2383764 | usd |
CY2022Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3793079 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1943457 | usd |
CY2022Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
182015 | usd |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
319590 | usd |
CY2022Q2 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
572567 | usd |
CY2021Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
360361 | usd |
CY2022Q2 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
901304 | usd |
CY2021Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
1123467 | usd |
CY2022Q2 | kern |
Accrued Contractors
AccruedContractors
|
551388 | usd |
CY2021Q4 | kern |
Accrued Contractors
AccruedContractors
|
1288730 | usd |
CY2022Q2 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
920736 | usd |
CY2021Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
681045 | usd |
CY2022Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
129590 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
346870 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
7050679 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6063520 | usd |
CY2020Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
17000000 | usd |
CY2020Q2 | kern |
Debt Purchase Price
DebtPurchasePrice
|
15000000 | usd |
CY2020Q2 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2021-10-05 | |
CY2021Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
20000000 | usd |
CY2021Q4 | kern |
Debt Purchase Price
DebtPurchasePrice
|
18000000 | usd |
CY2022Q1 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
15337000 | usd |
CY2021Q2 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
1572405 | usd |
CY2022Q2 | kern |
Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
|
294000 | usd |
CY2021Q2 | kern |
Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
|
16405 | usd |
CY2022Q2 | kern |
Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
|
163000 | usd |
CY2021Q2 | kern |
Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
|
3000 | usd |
CY2022Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
13388000 | usd |
CY2021Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
17305000 | usd |
CY2020Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
13398000 | usd |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
5380000 | usd | |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
9269677 | usd | |
kern |
Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
|
1727000 | usd | |
kern |
Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
|
2007677 | usd | |
kern |
Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
|
-264000 | usd | |
kern |
Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
|
16000 | usd | |
CY2022Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
13388000 | usd |
CY2021Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
6152000 | usd |
kern |
Equity Instrument Convertible Conversion Ratio
EquityInstrumentConvertibleConversionRatio
|
1 | pure | |
kern |
Termination Fee
TerminationFee
|
500000 | usd | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
53642667 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9645604 | shares | |
us-gaap |
Debt Instrument Convertible Conversion Price Decrease
DebtInstrumentConvertibleConversionPriceDecrease
|
0.3105 | ||
us-gaap |
Debt Instrument Convertible Conversion Price Increase
DebtInstrumentConvertibleConversionPriceIncrease
|
4.05 | ||
CY2022Q2 | kern |
Weighting To The Market Approach
WeightingToTheMarketApproach
|
0.50 | pure |
CY2022Q2 | kern |
Weighted To The Income Approach
WeightedToTheIncomeApproach
|
0.50 | pure |
kern |
Impairment Expenses
ImpairmentExpenses
|
23500000 | usd | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.0044 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.0008 | pure | |
us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
80% | ||
CY2022Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0.1 | usd |